Atlas Trials

Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients

Clinical trial NCT04880720 · COMPLETED

Trial details

NCT number
NCT04880720
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Study type
OBSERVATIONAL
SARS-Cov-2 InfectionRheumatoid Arthritis
Start date
2021-07-19
Primary completion
2022-05-16
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.